Australian Cancer Research Foundation announces biggest ever private grant

October 11, 2005

The Australian Cancer Research Foundation is paving the way for the next wave of cancer research with the announcement today of the biggest private grant ever of $5 million to help make cancer history.

The $5 million grant recipient will be decided by a panel of internationally recognised scientists, chaired by Professor Mathew Vadas and including Professor Sir David Lane. It will be awarded to an Australian researcher who provides the most compelling proposal for cancer research including potential cures for cancer, cancer prevention and the treatment of cancer patients.

"This is an exciting announcement for not only the scientific community but everybody who has been touched by cancer. The $5 million grant will be awarded to help fund what we hope will be a quantum leap in the field of cancer research. The ACRF grant will not exclude big picture, far-reaching proposals for seed funding if that's what it's going to take to move into the next wave of cancer research and innovations that matter. Anything is possible," ACRF Chairman Tom Dery said.

The next wave of cancer research projects may explore a number of promising areas. The proposals for the grant could cover everything from boosting the body's immune system to fight cancer or the absolutely fundamental area of cancer prevention right through to potential cures for cancer.

Cancer research projects could include broad areas of investigation such as:Speaking at the announcement today were three leading Australian cancer research scientists: Professor Peter Klinken from the West Australian Institute of Medical Research; Professor Michelle Haber, Sydney's Children's Cancer Institute of Australia; and Professor Mark Hogarth from Melbourne's Austin Research Institute.

Although specialising in different areas, all three agreed that the biotech revolution, combined with the Human Genome project (which enables identification of individual variations in genes), has unleashed huge potential for the prevention and treatment of all types of cancers.

Research scientists now have the ability to observe and influence the behaviour of cancer cells, the blood cells of the immune system, proteins and bio-markers.

"We will be looking to attract outstanding projects in Australia that may not have been previously embraced by Australian researchers - perhaps projects that have been considered beyond our capacity, or too radical," Mr Dery said.

The $5 million grant recipient will be announced in June next year.

Research Australia

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to